E. Raluy et al. / Tetrahedron: Asymmetry 20 (2009) 2167–2172
2171
(CH3), 55.8 (d, C-3, JC–P = 6.4 Hz), 63.9 (C-6), 74.7 (C-5), 79.7 (d,
C-4, JC–P = 3.2 Hz), 81.1 (C-2), 104.2 (C-1), 109.2 (CMe2), 112.2
(CMe2), 125.2 (CH@), 126.0 (CH@), 131.9 (C), 132.0 (C), 132.2
(CH@), 132.3 (C), 132.4 (C), 133.2 (CH@), 135.4 (CH@), 138.2 (C),
139.7 (C). Anal. Calcd for C28H36NO7P: C, 63.51; H, 6.85; N, 2.64.
Found: C, 63.48; H, 6.82; N, 2.65.
4. Experimental section
4.1. General considerations
All syntheses were performed by using standard Schlenk tech-
niques under an argon atmosphere. Solvents were purified using
standard procedures. Sugar amines were prepared from
L2e: Yield: 237 mg (42%). 31P NMR (C6D6), d: 146.9 (s, 1P). 1H
NMR (C6D6), d: 1.09 (s, 3H, CH3), 1.25 (s, 3H, CH3), 1.36 (s, 3H,
CH3), 1.52 (s, 3H, CH3), 3.37 (m, 2H, NH, H-3), 3.69 (m, 5H, H-2,
CH2 allyl), 3.82 (m, 2H, H-6, H-60), 3.91 (m, 1H, H-4), 4.34 (m, 1H,
D-glucose,
D
-fructose and
D
-galactose as described.7 Ligands L1a–g,7 L2a,7
L3c,7 L4–L5a7 and L6–L9a–g13 were prepared as previously de-
scribed. All other reagents were used in their commercially available
form. 1H, 13C{1H} and 31P{1H} NMR spectra were recorded on a Varian
Gemini 400 MHz spectrometer. The chemical shifts are referenced to
tetramethylsilane (1H and 13C) as the internal standard or to H3PO4
3
H-5), 5.13 (m, 4H, CH2@ allyl), 5.32 (d, 1H, H-1, J1–2 = 4.0 Hz),
6.07 (m, 2H, CH@ allyl), 6.9–7.2 (m, 6H, CH@). 13C NMR (C6D6), d:
25.5 (CH3), 26.6 (CH3), 26.9 (CH3), 27.0 (CH3), 35.7 (CH2 allyl),
58.6 (C-3), 68.0 (C-6), 78.0 (C-5), 80.9 (C-4), 81.6 (C-2), 104.8 (C-
1), 109.9 (CMe2), 112.6 (CMe2), 115.8 (CH2 allyl), 120.8 (CH@),
126.0 (C), 129.7 (C), 129.9 (CH@), 130.2 (CH@), 135.4 (C), 136.1
(C), 138.2 (CH@ allyl). Anal. Calcd for C30H36NO7P: C, 65.09; H,
6.55; N, 2.53. Found: C, 65.10; H, 6.53; N, 2.51.
(
31P) as the external standard. The 1H and 13C NMR spectral assign-
ments were determined by 1H–1H and 1H–13C correlation spectra.
4.2. General procedure for the preparation of ligands L1–L5a–g
L4b: Yield: 245 mg (38%). 31P NMR (C6D6), d: 147.8 (s, 1P). 1H
NMR (C6D6), d: 1.04 (s, 3H, CH3), 1.11 (s, 3H, CH3), 1.27 (s, 3H,
CH3), 1.44 (s, 3H, CH3), 1.49 (s, 9H, CH3, t-Bu), 1.51 (s, 9H, CH3, t-
Bu), 3.28 (s, 3H, CH3–O), 3.30 (s, 3H, CH3–O), 3.43 (m, 1H, H-6),
3.57 (m, 1H, H-60), 3.59 (m, 1H, H-1), 3.65 (m, 1H, H-10), 3.72 (m,
1H, NH), 3.75 (m, 1H, H-4), 4.40 (m, 1H, H-3), 4.42 (m, 1H, H-2),
7.0–7.2 (m, 4H, CH@). 13C NMR (C6D6), d: 24.4 (CH3), 25.7 (CH3),
26.5 (CH3), 26.8 (CH3), 31.6 (CH3, t-Bu), 31.7 (CH3, t-Bu), 35.0 (C,
t-Bu), 35.3 (C, t-Bu), 47.5 (d, C-6, JC–P = 12.1 Hz), 55.2 (CH3–O),
55.3 (CH3–O), 61.9 (C-1), 71.1 (C-3), 71.5 (C-4), 72.1 (C-2), 108.3
(CMe2), 109.3 (CMe2), 115.0 (CH@), 116.3 (CH@), 135.0 (C), 143.1
(C), 156.6 (C). Anal. Calcd for C34H48NO9P: C, 63.24; H, 7.49; N,
2.17. Found: C, 63.19; H, 7.50; N, 2.14.
Phosphorochloridite (2.2 mmol) produced in situ was dissolved
in toluene (5 mL) before pyridine (0.36 mL, 4.6 mmol) was added.
The amine (2 mmol) was azeotropically dried with toluene
(3 ꢂ 1 mL) and then dissolved in toluene (10 mL), to which pyri-
dine (0.36 mL, 4.6 mmol) was added. The amine solution was
transferred slowly at 0 °C to the solution of phosphorochloridite.
The reaction mixture was warmed to 80 °C and stirred overnight,
and the pyridine salts were removed by filtration. Evaporation of
the solvent gave a white foam, which was purified in a short path
of alumina (toluene/NEt3 = 100/1) to produce the corresponding li-
gand as a white powder or colourless liquid.
L2b: Yield: 284 mg (44%). 31P NMR (C6D6), d: 148.7 (s, 1P). 1H
NMR (C6D6), d: 1.02 (s, 3H, CH3), 1.23 (s, 3H, CH3), 1.35 (s, 3H,
CH3), 1.45 (s, 3H, CH3), 1.48 (s, 9H, CH3, t-Bu), 1.52 (s, 9H, CH3,
t-Bu), 3.04 (m, 1H, H-3), 3.24 (m, 1H, NH), 3.27 (s, 3H, CH3–O),
L4c: Yield: 228 mg (37%). 31P NMR (C6D6), d: 149.5 (s, 1P). 1H
NMR (C6D6), d: 0.40 (s, 9H, CH3–Si), 0.45 (s, 9H, CH3–Si), 1.06 (s,
3H, CH3), 1.09 (s, 3H, CH3), 1.29 (s, 3H, CH3), 1.39 (s, 3H, CH3),
3.27 (m, 1H, H-6), 3.38 (m, 1H, H-60), 3.60 (m, 1H, H-1), 3.67 (m,
1H, H-10), 3.73 (m, 1H, NH), 3.79 (m, 1H, H-4), 4.34 (m, 1H, H-3),
4.41 (m, 1H, H-2), 6.8–7.4 (m, 6H, CH@). 13C NMR (C6D6), d: 0.4
(CH3–Si), 0.5 (CH3–Si), 24.3 (CH3), 25.5 (CH3), 26.5 (CH3), 26.7
(CH3), 47.9 (d, C-6, JC–P = 8.2 Hz), 61.8 (C-1), 71.0 (C-3), 71.4 (C-
4), 72.2 (C-2), 108.3 (CMe2), 109.2 (CMe2), 124.9 (CH@), 126.0
(C), 129.6 (CH@), 131.9 (C), 132.0 (C), 135.8 (CH@), 135.9 (CH@),
136.5 (C), 138.2 (C), 155.7 (C). Anal. Calcd for C30H44NO7PSi2: C,
58.32; H, 7.18; N, 2.27. Found: C, 58.29; H, 7.16; N, 2.26.
´
3.29 (s, 3H, CH3–O), 3.76 (m, 1H, H-2), 3.89 (m, 1H, H-6), 3.92
(m, 1H, H-6), 4.00 (m, 1H, H-4), 4.52 (m, 1H, H-5), 5.33 (d, 1H, H-
3
1, J1–2 = 3.6 Hz), 6.62 (m, 1H, CH@), 6.70 (m, 1H, CH@), 7.11 (m,
2H, CH@). 13C NMR (C6D6), d: 26.2 (CH3), 26.4 (CH3), 28.8 (CH3),
28.9 (CH3), 31.4 (CH3, t-Bu), 31.6 (CH3, t-Bu), 35.7 (C, t-Bu), 35.8
(C, t-Bu), 55.2 (CH3–O), 55.4 (CH3–O), 55.8 (d, C-3, JC–P = 6.8 Hz),
64.0 (C-6), 75.7 (C-5), 79.8 (C-4), 80.3 (C-2), 104.3 (C-1), 109.6
(CMe2), 112.2 (CMe2), 112.5 (CH@), 113.8 (CH@), 114.9 (CH@),
115.0 (CH@), 134.8 (C), 134.9 (C), 143.0 (C), 143.2 (C), 156.4 (C),
156.7 (C). Anal. Calcd for C34H48NO9P: C, 63.24; H, 7.49; N, 2.17.
Found: C, 63.21; H, 7.52; N, 2.15.
L4d: Yield: 216 mg (41%). 31P NMR (C6D6), d: 144.4 (s, 1P). 1H
NMR (C6D6), d: 1.42 (s, 3H, CH3), 1.49 (s, 3H, CH3), 1.68 (s, 3H,
CH3), 1.73 (s, 3H, CH3), 2.49 (s, 6H, CH3), 2.73 (s, 6H, CH3), 3.74
(m, 1H, H-6), 3.94 (m, 1H, H-60), 4.03 (m, 1H, H-1), 4.05 (m, 1H,
H-10), 4.08 (m, 1H, NH), 4.13 (m, 1H, H-4), 4.76 (m, 1H, H-3),
4.80 (m, 1H, H-2), 7.3–7.5 (m, 4H, CH@). 13C NMR (C6D6), d: 17.1
(CH3), 21.1 (CH3), 24.3 (CH3), 25.6 (CH3), 26.4 (CH3), 26.8 (CH3),
46.7 (d, C-6, JC–P = 11.4 Hz), 61.9 (C-1), 71.1 (C-3), 71.4 (C-4), 71.8
(C-2), 108.4 (CMe2), 109.3 (CMe2), 128.3 (CH@), 128.6 (CH@),
131.6 (C), 131.7 (C), 133.6 (C). Anal. Calcd for C28H36NO7P: C,
63.51; H, 6.85; N, 2.64. Found: C, 63.46; H, 6.81; N, 2.63.
L2c: Yield: 315 mg (51%). 31P NMR (C6D6), d: 149.7 (s, 1P). 1HNMR
(C6D6), d: 0.35 (s, 3H, CH3–Si), 0.42 (s, 3H, CH3–Si), 1.04 (s, 3H, CH3),
1.26 (s, 3H, CH3), 1.36 (s, 3H, CH3), 1.43 (s, 3H, CH3), 2.87 (m, 1H, H-3),
3.12 (m, 1H, NH), 3.62 (m, 1H, H-2), 3.69 (m, 1H, H-6), 3.75 (m, 1H, H-
3
60), 3.97 (m, 1H, H-4), 4.65 (m, 1H, H-5), 5.26 (d, 1H, H-1, J1–
2 = 4.0 Hz), 6.7–7.4 (m, 6H, CH@). 13C NMR (C6D6), d: 0.5 (CH3–Si),
0.7 (CH3–Si), 26.5 (CH3), 26.7 (CH3), 26.9 (CH3), 27.0 (CH3), 55.4 (d,
C-3, JC–P = 1.6 Hz), 63.8 (C-6), 75.8 (C-5), 79.9 (d, C-4, JC–P = 1.6 Hz),
80.6 (C-2), 104.3 (C-1), 109.8 (CMe2), 112.4 (CMe2), 125.2 (CH@),
126.0 (CH@), 131.9 (C), 132.0 (C), 132.2 (CH@), 132.3 (C), 132.4 (C),
133.2 (CH@), 135.4 (CH@), 136.0 (CH@), 136.5 (C), 138.2 (C), 155.7
(C), 155.9 (C). Anal. Calcd for C30H44NO7PSi2: C, 58.32; H, 7.18; N,
2.27. Found: C, 58.36; H, 7.20; N, 2.24.
L4e: Yield: 265 mg (48%). 31P NMR (C6D6), d: 146.3 (s, 1P). 1H
NMR (C6D6), d: 1.06 (s, 3H, CH3), 1.09 (s, 3H, CH3), 1.32 (s, 3H,
CH3), 1.36 (s, 3H, CH3), 3.30 (m, 1H, H-6), 3.44 (m, 1H, H-60), 3.47
(m, 1H, H-1), 3.50 (m, 1H, H-10), 3.57 (m, 5H, NH, CH2 allyl), 4.41
(m, 2H, H-4, H-3), 5.07 (m, 5H, H-2, CH2@ allyl), 6.02 (m, 2H,
CH@ allyl), 6.9–7.4 (m, 6H, CH@). 13C NMR (C6D6), d: 24.3 (CH3),
25.6 (CH3), 26.5 (CH3), 26.8 (CH3), 35.2 (CH2 allyl), 35.4 (CH2 allyl),
47.0 (d, C-6, JC–P = 4.2 Hz), 61.8 (C-1), 71.0 (C-3), 71.4 (C-4), 71.9 (C-
2), 108.3 (CMe2), 109.2 (CMe2), 116.4 (CH2@ allyl), 116.6 (CH2@ al-
lyl), 124.9 (CH@), 125.0 (CH@), 126.3 (C), 128.8 (CH@), 130.3
(CH@), 133.1 (C), 133.2 (C), 137.3 (CH@ allyl), 137.5 (CH@ allyl).
L2d: Yield: 280 mg (53%). 31P NMR (C6D6), d: 150.2 (s, 1P). 1H
NMR (C6D6), d: 1.05 (s, 3H, CH3), 1.24 (s, 3H, CH3), 1.36 (s, 3H,
CH3), 1.43 (s, 3H, CH3), 2.11 (s, 3H, CH3), 2.16 (s, 6H, CH3), 2.24
(s, 3H, CH3), 2.29 (s, 3H, CH3), 2.89 (m, 1H, H-3), 3.11 (m, 1H,
NH), 3.64 (m, 1H, H-2), 3.72 (m, 1H, H-6), 3.78 (m, 1H, H-60),
3
3.99 (m, 1H, H-4), 4.66 (m, 1H, H-5), 5.32 (d, 1H, H-1, J1–
2 = 4.0 Hz), 6.7–7.4 (m, 4H, CH@). 13C NMR (C6D6), d: 17.1 (CH3),
17.7 (CH3), 25.8 (CH3), 26.5 (CH3), 26.7 (CH3), 26.9 (CH3), 27.0